MARKET

AEZS

AEZS

Aeterna Zentaris Inc
NASDAQ
2.220
-0.240
-9.76%
After Hours: 2.200 -0.02 -0.90% 17:01 10/03 EDT
OPEN
2.310
PREV CLOSE
2.460
HIGH
2.370
LOW
2.200
VOLUME
13.14K
TURNOVER
0
52 WEEK HIGH
4.400
52 WEEK LOW
2.200
MARKET CAP
10.78M
P/E (TTM)
-0.4761
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at AEZS last week (0925-0929)?
Weekly Report · 2d ago
Weekly Report: what happened at AEZS last week (0918-0922)?
Weekly Report · 09/25 11:07
Weekly Report: what happened at AEZS last week (0911-0915)?
Weekly Report · 09/18 11:02
Weekly Report: what happened at AEZS last week (0904-0908)?
Weekly Report · 09/11 11:00
Weekly Report: what happened at AEZS last week (0828-0901)?
Weekly Report · 09/05 00:51
Weekly Report: what happened at AEZS last week (0821-0825)?
Weekly Report · 08/28 11:06
H.C. Wainwright Keeps Their Buy Rating on Aeterna Zentaris (AEZS)
TipRanks · 08/10 10:35
Aeterna Zentaris GAAP EPS of -$0.52, revenue of $2.2M
Seeking Alpha · 08/09 18:48
More
About AEZS
Aeterna Zentaris Inc. is a Canada-based specialty biopharmaceutical company. The Company is developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products focused on areas of significant unmet medical need. The Company's lead product, macimorelin (Macrilen, Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The Company is also leveraging the clinical and compelling safety profile of macimorelin to develop it for the diagnosis of childhood-onset growth hormone deficiency (CGHD). The Company is engaged in the development of its therapeutic asset and has established a pre-clinical development pipeline to potentially address unmet medical needs across a number of indications, including neuromyelitis optica spectrum disorder (NMOSD), Parkinson's disease (PD), hypoparathyroidism and amyotrophic lateral sclerosis (ALS). Its therapeutic development pipeline includes AIM Biologicals, AEZS-150 and AEZS-130.

Webull offers kinds of AEterna Zentaris Inc. (USA) stock information, including NASDAQ:AEZS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AEZS stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading AEZS stock methods without spending real money on the virtual paper trading platform.